If your child or teen has a solid tumor, Seattle Children's team has the medical and surgical expertise they may need to not only survive, but thrive — from cancer diagnosis through treatment and lifelong follow-up care.
Seattle Children's Cancer and Blood Disorders Center is the only pediatric cancer center in the Pacific Northwest accredited by the Commission on Cancer of the American College of Surgeons. Read on to learn why U.S. News & World Report consistently ranks it as one of the nation's top pediatric oncology and cancer surgery centers.
Seattle Children's partners with you to define and personalize the best treatment plan for your child’s tumor and how the tumor affects them. Your Cancer and Blood Disorders team has special training and draws from many fields of pediatric medicine and surgery to treat your child’s specific type of tumor.
We treat the most complex cancer patients. Other hospitals refer patients to Seattle Children's with tumors that are difficult to safely remove.
"We trusted Dr. Waldhausen. He told us he would treat Isaac like his own child, and that gave us confidence. When the surgery was complete and the doctor said he believed he got the whole mass out, that was the best outcome we could have asked for."
— Kelli Williams
Mother of Isaac, who was diagnosed with high-risk neuroblastoma
"Aliyanna's care team makes her feel loved and welcome. They're like another family for us."
— Daisy Martinez
Mother of Aliyanna, who was born with a fibrosarcoma tumor on her spine
At Seattle Children's Cancer and Blood Disorders Center, our providers are specially trained and among the most experienced in the nation at treating solid tumors in babies, children and young adults. Meet our solid tumor oncology doctors, part of the comprehensive solid tumors care team.
This team treats conditions like:
"Caring for patients with sarcoma requires a team of experts in oncology, surgery, radiation oncology and rehabilitation services.
Our weekly multidisciplinary tumor meetings allow us to share our knowledge and experience to create the optimal treatment plan for each patient. In addition, the vast number of clinical trials offered at our center assures patients that they can access cutting-edge research focused on their diseases."
— Dr. Katie Albert, physician, Cancer and Blood Disorders Center
"We're helping kids with no other options. It's amazing to work in a place where we get to see patients go into remission and know we're making a difference."
— Jason Yokoyama, research scientist, Seattle Children's Research Institute
Our five-year survival rates are consistently among the best in the country for many types of solid tumors, including neuroblastomas and brain and thyroid tumors.
Our doctors are internationally recognized in solid tumor care and surgery. They lead national research groups like the Children's Oncology Group, the largest pediatric oncology consortium in the world.
Seattle Children's Cancer and Blood Disorders Center offers state-of-the-art cancer therapies and clinical trials often not available at other hospitals, including immunotherapy.
After treatment ends, our Cancer Survivor Program will help keep your child or teen healthy over the long term. We keep you informed about future health risks and partner with the Survivorship Program at Fred Hutch to transition survivors to adult care when they are ready.
Through our partnership in the Seattle Cancer Care Alliance, our patients benefit from the work of physician-scientists at Fred Hutch and UW Medicine, as well as at Seattle Children's. The National Cancer Institute has named our partnership a comprehensive cancer center.
Many children and families travel to Seattle Children's for cancer treatment and surgery.
We help you coordinate transportation and housing so you can stay focused on your child.
We have lots of experience helping families make the transition back home safely.
Find your hope. Get in touch today.
Email our team at CBDCintake@seattlechildrens.org
Give us a call: 206-987-2106
Not quite ready? Take a moment to get to know the team.